Victory Capital Management
BPMC

Victory Capital Management’s Blueprint Medicines BPMC Stock Holding History

Victory Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,625
Closed -$1.49M – 2432
2025
Q2 		$1.49M Sell
11,625
-3,680
-24% -$382K ﹤0.01% 1682
2025
Q1 		$1.35M Sell
15,305
-718
-4% -$70K ﹤0.01% 1666
2024
Q4 		$1.4M Sell
16,023
-174,338
-92% -$16M ﹤0.01% 1640
2024
Q3 		$17.6M Sell
190,361
-74,634
-28% -$7.41M 0.02% 894
2024
Q2 		$28.6M Buy
264,995
+58,796
+29% +$5.89M 0.03% 669
2024
Q1 		$19.6M Buy
206,199
+75,149
+57% +$6.45M 0.02% 826
2023
Q4 		$12.1M Buy
131,050
+124,517
+1,906% +$8.07M 0.01% 981
2023
Q3 		$328K Buy
6,533
+95
+1% +$5.08K ﹤0.01% 2097
2023
Q2 		$407K Sell
6,438
-149
-2% -$8.1K ﹤0.01% 2045
2023
Q1 		$296K Buy
6,587
+13
+0.2% +$586 ﹤0.01% 2145
2022
Q4 		$288K Sell
6,574
-11,490
-64% -$551K ﹤0.01% 2181
2022
Q3 		$1.19M Buy
18,064
+11,535
+177% +$741K ﹤0.01% 1658
2022
Q2 		$330K Sell
6,529
-674
-9% -$39.5K ﹤0.01% 2207
2022
Q1 		$420K Sell
7,203
-393,039
-98% -$28.2M ﹤0.01% 2186
2021
Q4 		$42.9M Buy
400,242
+393,124
+5,523% +$41.1M 0.04% 622
2021
Q3 		$732K Sell
7,118
-521,336
-99% -$48.5M ﹤0.01% 1990
2021
Q2 		$46.5M Buy
528,454
+65,797
+14% +$6.03M 0.04% 590
2021
Q1 		$45M Sell
462,657
-21,841
-5% -$2.18M 0.05% 588
2020
Q4 		$54.3M Sell
484,498
-133,903
-22% -$14.1M 0.06% 491
2020
Q3 		$57.3M Buy
618,401
+53,880
+10% +$4.15M 0.07% 414
2020
Q2 		$44M Sell
564,521
-763,721
-57% -$51.7M 0.06% 467
2020
Q1 		$77.7M Buy
1,328,242
+767,060
+137% +$49.4M 0.07% 430
2019
Q4 		$45M Sell
561,182
-77,730
-12% -$5.82M 0.05% 526
2019
Q3 		$46.9M Buy
638,912
+147,010
+30% +$12.7M 0.06% 465
2019
Q2 		$46.4M Buy
491,902
+19,620
+4% +$1.62M 0.09% 335
2019
Q1 		$37.8M Buy
472,282
+2,120
+0.5% +$157K 0.09% 370
2018
Q4 		$25.3M Buy
470,162
+15,600
+3% +$948K 0.06% 476
2018
Q3 		$35.5M Buy
454,562
+15,080
+3% +$1.05M 0.07% 451
2018
Q2 		$27.9M Sell
439,482
-29,320
-6% -$2.33M 0.06% 509
2018
Q1 		$43M Sell
468,802
-8,560
-2% -$738K 0.09% 350
2017
Q4 		$36M Buy
477,362
+59,500
+14% +$4.19M 0.08% 421
2017
Q3 		$29.1M Sell
417,862
-169,190
-29% -$9.04M 0.07% 479
2017
Q2 		$29.7M Sell
587,052
-170,650
-23% -$7.25M 0.07% 460
2017
Q1 		$30.3M Buy
757,702
+97,552
+15% +$3.49M 0.07% 468
2016
Q4 		$18.5M Sell
660,150
-155,260
-19% -$4.68M 0.05% 585
2016
Q3 		$24.2M Buy
+815,410
New +$20.3M 0.07% 503

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Victory Capital Management's BPMC Position: Q3 2025 in Review

Victory Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 11,625 shares — an estimated $1.49M sold.

Victory Capital Management first reported a position in BPMC in Q3 2016 and held it in 36 quarters. The position peaked at $77.7M in Q1 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Victory Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Victory Capital Management sold 11,625 Blueprint Medicines shares in Q3 2025, an estimated $1.49M.
  • Victory Capital Management first reported a position in Blueprint Medicines in Q3 2016 and held it in 36 quarters.
  • Victory Capital Management's Blueprint Medicines position peaked at $77.7M in Q1 2020.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Victory Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.